You just read:

New Study Demonstrates Non-Invasive Prenatal Testing in High-Risk Women at Price Point of $795 is Clinically Beneficial and Cost-Saving to the Healthcare System

News provided by

Ariosa Diagnostics

Jan 29, 2013, 09:02 EST